Skip to main
OFIX

Orthofix International (OFIX) Stock Forecast & Price Target

Orthofix International (OFIX) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Orthofix Medical is well-positioned for growth, with a strong presence in the global spine market and a growing orthopedic segment. The company's recent streamlining activities and affirmation of financial guidance further demonstrate its stable and efficient operations. Improved expenses and potential updates, such as guidance for 2026, also bode well for the company's future performance. With expected strong revenue numbers for the quarter, especially in global spine, and a healthy cash position, Orthofix Medical is a solid investment opportunity.

Bears say

Orthofix Medical is facing some challenges as seen in the flat revenue growth in Q1, which is lower than both analysts' and our estimate. The company heavily relies on its spine segment for revenue and there is potential risk if this segment does not perform well in the future. Additionally, using EV/EBITDA as a valuation method poses risks as the company may not meet earnings estimates.

Orthofix International (OFIX) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Orthofix International (OFIX) Forecast

Analysts have given Orthofix International (OFIX) a Buy based on their latest research and market trends.

According to 4 analysts, Orthofix International (OFIX) has a Buy consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Orthofix International (OFIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.